PULMONX CORPORATION Increase (Decrease) in Inventories
PULMONX CORPORATION (LUNG) reported Increase (Decrease) in Inventories of $1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- PULMONX CORPORATION increase (decrease) in inventories for the quarter ending 2026-06-30 was $248.00K.
- PULMONX CORPORATION increase (decrease) in inventories for the quarter ending 2026-03-31 was $959.00K.
- PULMONX CORPORATION increase (decrease) in inventories for the quarter ending 2025-12-31 was $810.00K, a 429.41% increase year-over-year.
- PULMONX CORPORATION increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.02M.
- PULMONX CORPORATION increase (decrease) in inventories for fiscal 2025 was $765.00K, a 234.06% increase from fiscal 2024.
- PULMONX CORPORATION increase (decrease) in inventories for fiscal 2024 was $229.00K.
- PULMONX CORPORATION increase (decrease) in inventories for fiscal 2023 was -$918.00K, a 125.23% decline from fiscal 2022.
- PULMONX CORPORATION increase (decrease) in inventories for fiscal 2022 was $3.64M, a 43.67% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.21M 10-Q · filed 2026-08-04 | $2.02M derived: sum of 3 quarters · filed 2026-08-04 | $3.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $959.00K 10-Q · filed 2026-05-04 | $1.77M derived: sum of 2 quarters · filed 2026-05-04 | $2.79M derived: sum of 3 quarters · filed 2026-05-04 | $2.13M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $810.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.83M derived: sum of 2 quarters · filed 2026-03-10 | $1.17M derived: sum of 3 quarters · filed 2026-08-04 | $765.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $361.00K derived: sum of 2 quarters · filed 2026-08-04 | -$45.00K 10-Q · filed 2025-11-12 | $108.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$660.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.07M 10-Q · filed 2026-08-04 | -$913.00K derived: sum of 3 quarters · filed 2026-08-04 | -$1.51M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$406.00K 10-Q · filed 2026-05-04 | -$253.00K derived: sum of 2 quarters · filed 2026-05-04 | -$849.00K derived: sum of 3 quarters · filed 2026-05-04 | -$1.26M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$443.00K derived: sum of 2 quarters · filed 2026-03-10 | -$855.00K derived: sum of 3 quarters · filed 2026-03-10 | $229.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$596.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.01M derived: sum of 2 quarters · filed 2025-11-12 | $76.00K 10-Q · filed 2025-11-12 | -$1.27M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $672.00K 10-Q · filed 2025-08-01 | -$677.00K derived: sum of 3 quarters · filed 2025-08-01 | -$513.00K derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $1.08M 10-Q · filed 2025-05-02 | -$265.00K derived: sum of 2 quarters · filed 2025-05-02 | -$101.00K derived: sum of 3 quarters · filed 2025-05-02 | -$438.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$1.19M derived: sum of 2 quarters · filed 2025-02-25 | -$1.52M derived: sum of 3 quarters · filed 2025-02-25 | -$918.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$173.00K derived: sum of 2 quarters · filed 2024-11-01 | $431.00K 10-Q · filed 2024-11-01 | -$105.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $267.00K 10-Q · filed 2024-08-02 | -$269.00K derived: sum of 3 quarters · filed 2024-08-02 | $875.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $604.00K 10-Q · filed 2024-05-03 | $68.00K derived: sum of 2 quarters · filed 2024-05-03 | $1.21M derived: sum of 3 quarters · filed 2024-05-03 | $2.22M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $608.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.62M derived: sum of 3 quarters · filed 2024-02-27 | $3.64M 10-K · filed 2024-02-27 |
| 2022-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $2.15M derived: sum of 2 quarters · filed 2023-11-03 | $4.17M 10-Q · filed 2023-11-03 | $5.63M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $3.03M 10-Q · filed 2023-08-04 | $4.48M derived: sum of 3 quarters · filed 2023-08-04 | $6.36M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $2.02M 10-Q · filed 2023-05-08 | $3.47M derived: sum of 2 quarters · filed 2023-05-08 | $5.35M derived: sum of 3 quarters · filed 2023-05-08 | $6.85M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.33M derived: sum of 2 quarters · filed 2023-03-01 | $4.83M derived: sum of 3 quarters · filed 2023-03-01 | $6.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.38M derived: sum of 2 quarters · filed 2022-11-08 | $5.01M 10-Q · filed 2022-11-08 | $6.11M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.13M 10-Q · filed 2022-08-08 | $4.23M derived: sum of 3 quarters · filed 2022-08-08 | $5.12M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.63M 10-Q · filed 2022-05-09 | $2.73M derived: sum of 2 quarters · filed 2022-05-09 | $3.62M derived: sum of 3 quarters · filed 2022-05-09 | $4.49M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.99M derived: sum of 2 quarters · filed 2022-03-01 | $2.86M derived: sum of 3 quarters · filed 2022-03-01 | $5.05M 10-K · filed 2022-03-01 |
| 2020-09-30 | $890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.75M derived: sum of 2 quarters · filed 2021-11-09 | $3.94M 10-Q · filed 2021-11-09 | $4.42M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $865.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $3.05M 10-Q · filed 2021-08-10 | $3.53M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $2.19M 10-Q · filed 2021-05-12 | $2.66M derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.61M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $2.14M 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $1.25M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |